本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Centessa Pharmaceuticals plc

39.39
-0.0950-0.24%
成交量:129.46萬
成交額:5,094.14萬
市值:60.88億
市盈率:-26.98
高:39.53
開:39.50
低:39.16
收:39.48
52周最高:40.26
52周最低:10.95
股本:1.55億
流通股本:8,933.05萬
量比:1.42
換手率:1.45%
股息:- -
股息率:- -
每股收益(TTM):-1.4600
每股收益(LYR):-1.4600
淨資產收益率:-42.55%
總資產收益率:-20.53%
市淨率:11.55
市盈率(LYR):-26.98

資料載入中...

2024/10/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/10/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/10/18

[修訂]季度報告

Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
2024/09/25

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/13

重要事件披露

Form 8-K - Current report
2024/09/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/10

重要事件披露

Form 8-K - Current report
2024/09/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/23

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/23

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/13

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/13

重要事件披露

Form 8-K - Current report
2024/06/26

重要事件披露

Form 8-K - Current report
2024/06/10

重要事件披露

Form 8-K - Current report